← Back to Search

Group 2 for Sleep Disorder

Rothman Orthopaedic Institute, Philadelphia, PA
Targeting 2 different conditionsmelatonin 6mg +1 moreN/AWaitlist AvailableResearch Sponsored by Rothman Institute Orthopaedics

Study Summary

This study is evaluating whether melatonin when used as a supplement after surgery improves sleep following total joint arthroplasty.

Eligible Conditions
  • Sleep Disorder
  • Total Joint Replacement

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient Sleep Quality

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Group 2Active Control1 Intervention
Melatonin (6mg)
Group II: Group 1Placebo Group1 Intervention
Placebo Tablet

Find a Location

Who is running the clinical trial?

Rothman Institute OrthopaedicsLead Sponsor
121 Previous Clinical Trials
21,424 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~23 spots leftby Nov 2024